Convergent Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$40M
Convergent Therapeutics is a clinical-stage biotechnology company developing radiopharmaceutical treatments for cancer, including a lead candidate for metastatic castration-resistant prostate cancer.
Focus Areas
biotechnology
radiopharmaceuticals
clinical trials
prostate cancer
drug development
cancer biology
Investors
